211 related articles for article (PubMed ID: 25882892)
1. Validation of new cancer biomarkers: a position statement from the European group on tumor markers.
Duffy MJ; Sturgeon CM; Sölétormos G; Barak V; Molina R; Hayes DF; Diamandis EP; Bossuyt PM
Clin Chem; 2015 Jun; 61(6):809-20. PubMed ID: 25882892
[TBL] [Abstract][Full Text] [Related]
2. Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation.
Masucci GV; Cesano A; Hawtin R; Janetzki S; Zhang J; Kirsch I; Dobbin KK; Alvarez J; Robbins PB; Selvan SR; Streicher HZ; Butterfield LH; Thurin M
J Immunother Cancer; 2016; 4():76. PubMed ID: 27895917
[TBL] [Abstract][Full Text] [Related]
3. Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations.
Dobbin KK; Cesano A; Alvarez J; Hawtin R; Janetzki S; Kirsch I; Masucci GV; Robbins PB; Selvan SR; Streicher HZ; Zhang J; Butterfield LH; Thurin M
J Immunother Cancer; 2016; 4():77. PubMed ID: 27891226
[TBL] [Abstract][Full Text] [Related]
4. The long journey of cancer biomarkers from the bench to the clinic.
Pavlou MP; Diamandis EP; Blasutig IM
Clin Chem; 2013 Jan; 59(1):147-57. PubMed ID: 23019307
[TBL] [Abstract][Full Text] [Related]
5. Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor Markers.
Sölétormos G; Duffy MJ; Hayes DF; Sturgeon CM; Barak V; Bossuyt PM; Diamandis EP; Gion M; Hyltoft-Petersen P; Lamerz RM; Nielsen DL; Sibley P; Tholander B; Tuxen MK; Bonfrer JM
Clin Chem; 2013 Jan; 59(1):52-9. PubMed ID: 23034139
[TBL] [Abstract][Full Text] [Related]
6. Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives.
Mordente A; Meucci E; Martorana GE; Silvestrini A
Adv Exp Med Biol; 2015; 867():9-26. PubMed ID: 26530357
[TBL] [Abstract][Full Text] [Related]
7. Garbage in, garbage out: a critical evaluation of strategies used for validation of immunohistochemical biomarkers.
O'Hurley G; Sjöstedt E; Rahman A; Li B; Kampf C; Pontén F; Gallagher WM; Lindskog C
Mol Oncol; 2014 Jun; 8(4):783-98. PubMed ID: 24725481
[TBL] [Abstract][Full Text] [Related]
8. Cancer biomarker validation: standards and process: roles for the National Institute of Standards and Technology (NIST).
Barker PE
Ann N Y Acad Sci; 2003 Mar; 983():142-50. PubMed ID: 12724219
[TBL] [Abstract][Full Text] [Related]
9. The early detection research network: 10-year outlook.
Srivastava S
Clin Chem; 2013 Jan; 59(1):60-7. PubMed ID: 23160065
[TBL] [Abstract][Full Text] [Related]
10. Joint National Cancer Institute-Food and Drug Administration workshop on research strategies, study designs, and statistical approaches to biomarker validation for cancer diagnosis and detection.
Maruvada P; Srivastava S
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1078-82. PubMed ID: 16775163
[TBL] [Abstract][Full Text] [Related]
11. Efficient, Adaptive Clinical Validation of Predictive Biomarkers in Cancer Therapeutic Development.
Beckman RA; Chen C
Adv Exp Med Biol; 2015; 867():81-90. PubMed ID: 26530361
[TBL] [Abstract][Full Text] [Related]
12. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
Valentin MA; Ma S; Zhao A; Legay F; Avrameas A
J Pharm Biomed Anal; 2011 Jul; 55(5):869-77. PubMed ID: 21530130
[TBL] [Abstract][Full Text] [Related]
13. The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers.
Feng Z; Kagan J; Pepe M; Thornquist M; Ann Rinaudo J; Dahlgren J; Krueger K; Zheng Y; Patriotis C; Huang Y; Sorbara L; Thompson I; Srivastava S
Clin Chem; 2013 Jan; 59(1):68-74. PubMed ID: 23193062
[TBL] [Abstract][Full Text] [Related]
14. Design of a binary biomarker study from the results of a pilot study.
Albert PS; Mcshane LM; Korn EL
Biometrics; 2002 Sep; 58(3):576-85. PubMed ID: 12229992
[TBL] [Abstract][Full Text] [Related]
15. The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis.
Paradiso A; Mangia A; Orlando C; Verderio P; Belfiglio M; Marchetti A; Bertario L; Chiappetta G; Gion M; Tonini GP; Podo F; Vocaturo A; Silvestrini R; Romani M; Belloni E; Cavallo D; Ulivi P; Tommasi S; Steffan A; Russo A; Alessio M; Calistri D; Zancan M; Parrela P; Broggini M; Giuseppe A; Buttitta F; Finocchiaro G; Mazzocco K; Veronesi G; Landuzzi L; Benevolo M; Mariani L; De Marco F; Venuti A; Giannelli G; Quaranta M; Trojano V
Int J Biol Markers; 2009; 24(3):119-29. PubMed ID: 19787622
[TBL] [Abstract][Full Text] [Related]
16. Cancer biomarkers: easier said than done.
Pritzker KP
Clin Chem; 2002 Aug; 48(8):1147-50. PubMed ID: 12142366
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers: diagnostic highlights and surrogate end points. Cambridge Healthtech Institute's biomarker series: biomarker validation: bringing discovery to the clinic & cancer biomarkers: from discovery to clinical practice. May 3-5, 2004, Philadelphia, Pennsylvania, USA.
Levenson VV
Pharmacogenomics; 2004 Jul; 5(5):459-61. PubMed ID: 15212582
[No Abstract] [Full Text] [Related]
18. Biomarker research with prospective study designs for the early detection of cancer.
Pesch B; Brüning T; Johnen G; Casjens S; Bonberg N; Taeger D; Müller A; Weber DG; Behrens T
Biochim Biophys Acta; 2014 May; 1844(5):874-83. PubMed ID: 24361552
[TBL] [Abstract][Full Text] [Related]
19. Study Design Considerations for Cancer Biomarker Discoveries.
Zheng Y
J Appl Lab Med; 2018 Sep; 3(2):282-289. PubMed ID: 30828695
[TBL] [Abstract][Full Text] [Related]
20. Biomarker analysis for oncology.
Ma Y; Gamagedara S
Biomark Med; 2015; 9(9):845-50. PubMed ID: 26330199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
